TANASI, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 248
EU - Europa 225
AS - Asia 179
AF - Africa 13
OC - Oceania 2
Totale 667
Nazione #
US - Stati Uniti d'America 244
SG - Singapore 68
CN - Cina 58
IT - Italia 47
RU - Federazione Russa 34
SE - Svezia 27
FR - Francia 26
IE - Irlanda 23
DE - Germania 22
HK - Hong Kong 19
VN - Vietnam 18
GB - Regno Unito 10
ES - Italia 8
FI - Finlandia 8
ID - Indonesia 6
TG - Togo 6
AT - Austria 4
CA - Canada 4
EG - Egitto 4
NL - Olanda 4
BE - Belgio 3
PT - Portogallo 3
TR - Turchia 3
AU - Australia 2
CH - Svizzera 2
JP - Giappone 2
KR - Corea 2
LT - Lituania 2
MA - Marocco 2
HU - Ungheria 1
KH - Cambogia 1
MU - Mauritius 1
SA - Arabia Saudita 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 667
Città #
Chandler 77
Singapore 61
Dublin 22
Hong Kong 19
Ashburn 16
Beijing 13
New York 12
Verona 9
Wilmington 9
Dong Ket 8
Lawrence 8
Princeton 8
Falls Church 7
Helsinki 7
Sindelfingen 7
Jakarta 6
Lomé 6
Southend 6
Barcelona 5
Kent 5
Redmond 5
Cagliari 4
Giza 4
Montichiari 4
Norwalk 4
Amsterdam 3
Brussels 3
Chicago 3
Council Bluffs 3
Esslingen am Neckar 3
Jacksonville 3
Milan 3
Munich 3
Ottawa 3
Tianjin 3
Vienna 3
Washington 3
Abbotsford 2
Bologna 2
Dallas 2
Illasi 2
Jinan 2
Lisbon 2
Moscow 2
Paris 2
Pionca 2
Redwood City 2
Reggiolo 2
Santa Clara 2
Seoul 2
Tokyo 2
Zurich 2
Ann Arbor 1
Buffalo 1
Böblingen 1
Büdelsdorf 1
Cento 1
Changsha 1
Columbus 1
Evanston 1
Fairfield 1
Fuzhou 1
Guangzhou 1
Haikou 1
Hamburg 1
Hangzhou 1
Harbin 1
Hebei 1
Jiaxing 1
Lanzhou 1
Lappeenranta 1
Los Angeles 1
Nanjing 1
Phnom Penh 1
Porto 1
Riva 1
Romola 1
Seattle 1
Sesto San Giovanni 1
Shenyang 1
Shijiazhuang 1
Sopron 1
Soverato Marina 1
Tashkent 1
Toronto 1
Trieste 1
Woodbridge 1
Totale 433
Nome #
Notch Signaling Molecules as Prognostic Biomarkers for Acute Myeloid Leukemia 77
The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population 73
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia 72
Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements 66
Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice 59
High-throughput analysis and functional interpretation of extracellular vesicle content in hematological malignancies 57
Extracellular Vesicle-Dependent Communication Between Mesenchymal Stromal Cells and Immune Effector Cells 57
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network 51
Scoring proposal to address bone marrow evaluation in patients with severe unexplained osteoporosis and suspected systemic mastocytosis 43
Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia 28
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study 26
Update on the Role and Utility of Extracellular Vesicles in Hematological Malignancies 20
Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis 18
BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life study 14
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis 12
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front‐line with paediatric‐inspired regimens: A retrospective multicentre Campus ALL study 11
Successful rechallenge with azacytidine and venetoclax after sustained treatment-free remission in a relapsed acute myeloid leukemia patient: a case report 10
Totale 694
Categoria #
all - tutte 3.381
article - articoli 3.217
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 164
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 0 2 1 3 1 3
2020/202145 3 1 0 1 4 9 2 0 5 0 2 18
2021/202286 1 20 16 4 6 7 7 5 3 2 3 12
2022/2023182 9 28 18 37 8 43 0 4 19 3 9 4
2023/2024145 3 2 13 13 14 19 5 5 0 14 50 7
2024/2025226 12 34 36 103 16 25 0 0 0 0 0 0
Totale 694